Upregulation of estrogen receptor alpha (ERα) expression in transgenic mice expressing human CYP4Z1

被引:3
作者
Khayeka-Wandabwa, Christopher [1 ]
Zhao, Jie [1 ]
Pathak, Janak L. [1 ,2 ]
Wu, Huiyuan [1 ]
Bureik, Matthias [1 ]
机构
[1] Tianjin Univ, Sch Pharmaceut Sci & Technol SPST, Tianjin, Peoples R China
[2] Guangzhou Med Univ, Affiliated Stomatol Hosp, Guangzhou Inst Oral Dis, Guangzhou, Peoples R China
关键词
Breast cancer; ER; Transgenic mice; CAPILLARY FORMATION; BREAST-CANCER; MAMMARY-GLAND; IN-VIVO; CYTOCHROME-P450; PROTEIN; ENZYME; MODELS;
D O I
10.1007/s10549-021-06435-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose CYP4Z1 is a human cytochrome P450 enzyme involved in breast cancer progression and prognosis, but its functional role in these processes is not understood. In order to gain more insight into CYP4Z1's properties it was recombinantly expressed in a host animal that does not have an endogenous homologue. Methods We generated a transgenic mouse model that specifically expresses human CYP4Z1 in breast tissue under the control of the whey acidic protein promoter. Complementary experiments were done using cell lines derived from human breast cell. Results Induction of CYP4Z1 expression led to reduction of body weight, activity, and birth rates. Histological analysis revealed no evidence for tumor formation. However, a strong increase in estrogen receptor alpha was observed by immunohistochemistry; weaker but significantly increased immunoreactivity was also detected for collagen I and fibronectin. Overexpression of CYP4Z1 in the human breast cancer cell line MCF7 also led to increased ER alpha expression. Moreover, increased expression of both CYP4Z1 and ER alpha was observed in MCF-10A normal breast cells upon cocultivation with MCF-7 cells (with or without overexpression of CYP4Z1). Conclusion These data suggest that CYP4Z1 facilitates breast cancer development by induction of ER alpha expression via an as yet undefined mechanism.
引用
收藏
页码:319 / 326
页数:8
相关论文
共 36 条
[1]  
Burkholder Tanya, 2012, Curr Protoc Mouse Biol, V2, P145
[2]  
Caligioni Claudia S, 2009, Curr Protoc Neurosci, VAppendix 4, p4I, DOI 10.1002/0471142301.nsa04is48
[3]   How to calculate sample size in animal studies? [J].
Charan, Jaykaran ;
Kantharia, N. D. .
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (04) :303-306
[4]   Efficient transposition of the piggyBac resource (PB) transposon in mammalian cells and mice [J].
Ding, S ;
Wu, XH ;
Li, G ;
Han, M ;
Zhuang, Y ;
Xu, T .
CELL, 2005, 122 (03) :473-483
[5]   Functional expression and activity screening of all human cytochrome P450 enzymes in fission yeast [J].
Durairaj, Pradeepraj ;
Fan, Linbing ;
Du, Wei ;
Ahmad, Shabir ;
Mebrahtu, Dawit ;
Sharma, Shishir ;
Ashraf, Rana Azeem ;
Liu, Jiaxin ;
Liu, Qian ;
Bureik, Matthias .
FEBS LETTERS, 2019, 593 (12) :1372-1380
[6]   Mouse models of breast cancer metastasis [J].
Fantozzi, Anna ;
Christofori, Gerhard .
BREAST CANCER RESEARCH, 2006, 8 (04)
[7]   Design and statistical methods in studies using animal models of development [J].
Festing, MFW .
ILAR JOURNAL, 2006, 47 (01) :5-14
[8]  
Festing Michael F W, 2002, ILAR J, V43, P244
[9]  
Foltz CJ, 1999, LAB ANIMAL, V28, P28
[10]  
Hrycay Eugene G, 2015, Adv Pharmacol, V74, P35, DOI 10.1016/bs.apha.2015.03.003